Nomogram to predict 3 month prognosis of acute ischemic stroke among young adults
Authors:
Open Access
- 30 January 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1487248
Abstract
Objective: This study aimed to develop and validate a nomogram for predicting the risk of 3 months adverse outcomes among young adults with acute ischemic stroke (AIS).Methods: Patients aged between 18 and 50 with acute ischemic stroke (AIS) at the Shenyang First’s People Hospital, between January 1st 2017 to May 30th 2023 were included in this retrospective study. The primary outcome was a three-month unfavorable outcome, evaluated with modified Rankin Scale (mRS > 2). Univariate logistic regression was used to select the independent factors of prognosis and multivariate logistic regression to establish a new nomogram model. We used the area under the receiver-operating characteristic curve (ROC) to evaluate the discriminative performance and used the calibration curve with Hosmer-Lemeshow goodness of fit test to assess the calibration performance of the risk prediction model. Decision curve analysis (DCA) was applied to assess the clinical utility of the nomogram.Results: A total of 1,015 patients were enrolled. Gender (male vs. female; Odds ratio[OR], 0.5562[95% Confidence Interval (CI), 0.3104–1.0478]; p = 0.053), family history of stroke (OR, 3.5698[95%CI 1.5632–8.0329], p < 0.001), prior stroke (OR, 2.1509[95%CI 1.2610–3.6577], p < 0.001), previous heart disease (OR, 3.4047[95%CI, 1.7838–6.6976], p < 0.01) toast type (cardio-embolism stroke vs. large-artery atherosclerosis (LAA), OR, 0.0847[0.0043–0.5284], p < 0.01), toast type (stroke of undetermined etiology vs. LAA, OR, 0.0847[0.0439–0.5284], p < 0.01), mRS at admission (OR, 15.2446 [9.1447–26.3156], p < 0.0001), adherence to medication (OR, 2.1197[95%CI, 1.1924–3.7464], p < 0.001), systolic blood pressure (SBP; OR, 1.0145[1.0041–1.0250], p < 0.001), and lactate dehydrogenase (LDH; OR, 1.0060[1.0010–1.0111], p < 0.01) were related to 3 months adverse outcomes among young adults with AIS. The nomogram displayed excellent calibration and discrimination. DCA confirmed the clinical applicability of the model.Conclusion: The nomogram comprised of gender, family history of stroke, prior stroke, previous heart disease, toast type, mRS score at admission, adherence to medication, SBP and LDH may predict 3 months adverse outcomes among young adults with AIS.Keywords
This publication has 31 references indexed in Scilit:
- Systolic blood pressure trajectories after acute ischemic strokes and clinical outcomes: A systematic reviewThe Journal of Clinical Hypertension, 2022
- Previous Disability and Benefit of Acute Phase Therapy in Functional Prognosis of Selected Patients with Ischemic StrokeJournal of Stroke and Cerebrovascular Diseases, 2022
- Acute‐phase blood pressure trajectories and clinical outcomes in ischemic strokeThe Journal of Clinical Hypertension, 2019
- Stroke genetics: discovery, biology, and clinical applicationsThe Lancet Neurology, 2019
- A review on coronary artery disease, its risk factors, and therapeuticsJournal of Cellular Physiology, 2019
- Epidemiology, aetiology, and management of ischaemic stroke in young adultsThe Lancet Neurology, 2018
- Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approachesEuropean Journal of Pharmacology, 2018
- Challenges and opportunities in stroke geneticsCardiovascular Research, 2018
- Statin and Aspirin Pretreatment Are Associated with Lower Neurological Deterioration and Platelet Activity in Patients with Acute Ischemic StrokeJournal of Stroke and Cerebrovascular Diseases, 2017
- Molecular dialogs between the ischemic brain and the peripheral immune system: Dualistic roles in injury and repairProgress in Neurobiology, 2014